Top 5 HIV Stories from CROI 2025: New Treatments, HIV Remission Insights, and More

Top 5 HIV Stories from CROI 2025: New Treatments, HIV Remission Insights, and More

Source: Contagionlive.com

Studies presented included once-yearly lenacapavir formulations for PrEP, bictegravir outperforming darunavir in advanced HIV, Immunocore's IMC-M113V showing viral control and reservoir reduction, and more.

Moupali Das, MD, MPH, presented results from a Phase 1 study of two once-yearly intramuscular (IM) formulations of lenacapavir for HIV pre-exposure prophylaxis (PrEP). Both formulations demonstrated strong pharmacokinetic profiles, with lenacapavir c… [4977 chars]

Read more